K&P Scientific LLC and Experimentica Ltd., a Finland-based clinical research organization specializing in preclinical ocular models and ophthalmic drug discovery, have published an Editorial in the Austin Journal of Clinical Ophthalmology, calling for the early use of relevant functional endpoints in ophthalmic drug discovery. The Editorial has been published under Open Access License (PDF) and is expected to reach a broad scholarly audience of academic researchers, clinician scientists and the CRO community. Citation: Kalesnykas G, Rawal AS and Kaja S. The Need for Relevant Functional Endpoints in Ophthalmic Drug Discovery. Austin J Clin Ophthalmol. 2014;1(6): 2 (PDF).